Literature DB >> 11254613

Transcriptional regulation of divergent capsule biosynthesis and transport operon promoters in serogroup B Neisseria meningitidis.

Y L Tzeng1, J S Swartley, Y K Miller, R E Nisbet, L J Liu, J H Ahn, D S Stephens.   

Abstract

The clinically important serogroups B, C, Y, and W-135 of Neisseria meningitidis produce sialic acid capsules that are critical in pathogenesis. In each of these serogroups, the capsule transport (ctrABCD) and capsule biosynthesis (synABCD) operons are divergently transcribed from putative promoters located in a 134-bp intergenic region (J. S. Swartley, J. H. Ahn, L. J. Liu, C. M. Kahler, and D. S. Stephens, J. Bacteriol. 178:4052-4059, 1996). In this study we further assessed the role of the intergenic sequence in the transcriptional regulation of the sialic acid capsules of N. meningitidis. Insertional mutagenesis or deletions of the 134-bp sequence in the serogroup B meningococcal strain NMB resulted in a marked reduction or elimination of ctrABCD and synABCD transcription, with a concomitant loss of encapsulation. Chromosomal transcriptional lacZ-ermC reporter fusions of syn and ctr promoters were constructed through allelic exchange. Using these constructs, both operons were found to be constitutively transcribed in meningococci, the biosynthesis operon about fourfold higher than the transport operon. Both promoters showed increased activity during stationary-phase growth. In addition to the promoters, a 70-bp 5' untranslated region (UTR) upstream of synA was found to have a direct repeat and an inverted repeat that overlapped three putative integration host factor binding sites. Mutation of this 70-bp UTR and of the direct repeat upregulated both syn and ctr transcription. Regulation through the synA UTR was absent in a K1 Escherichia coli strain that produces identical capsular polysaccharide, implicating species-specific regulation. Meningococcal sialic acid capsule expression is initiated by divergent promoters in a 134-bp intergenic region, is repressed at the transcriptional level by the 5' UTR of synA, is increased during stationary-phase growth, and shows species-specific regulation. Transcriptional regulation is another important control point for sialic capsule expression in N. meningitidis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254613      PMCID: PMC98185          DOI: 10.1128/IAI.69.4.2502-2511.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules.

Authors:  H Claus; U Vogel; M Mühlenhoff; R Gerardy-Schahn; M Frosch
Journal:  Mol Gen Genet       Date:  1997-12

Review 2.  Structure, assembly and regulation of expression of capsules in Escherichia coli.

Authors:  C Whitfield; I S Roberts
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

3.  A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.

Authors:  A Heath; V J DiRita; N L Barg; N C Engleberg
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

Authors:  J S Swartley; J H Ahn; L J Liu; C M Kahler; D S Stephens
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

5.  Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis.

Authors:  J S Swartley; L J Liu; Y K Miller; L E Martin; S Edupuganti; D S Stephens
Journal:  J Bacteriol       Date:  1998-03       Impact factor: 3.490

6.  Capsule switching of Neisseria meningitidis.

Authors:  J S Swartley; A A Marfin; S Edupuganti; L J Liu; P Cieslak; B Perkins; J D Wenger; D S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

7.  Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.

Authors:  S Hammerschmidt; A Müller; H Sillmann; M Mühlenhoff; R Borrow; A Fox; J van Putten; W D Zollinger; R Gerardy-Schahn; M Frosch
Journal:  Mol Microbiol       Date:  1996-06       Impact factor: 3.501

8.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Genetic Transformation as a tool for detection of Neisseria gonorrhoeae.

Authors:  A Janik; E Juni; G A Heym
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

10.  Physiology of sialic acid capsular polysaccharide synthesis in serogroup B Neisseria meningitidis.

Authors:  L Masson; B E Holbein
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

View more
  13 in total

1.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Authors:  C Hal Jones; Naglaa Mohamed; Eduardo Rojas; Lubomira Andrew; Johanna Hoyos; Julio C Hawkins; Lisa K McNeil; Qin Jiang; Leonard W Mayer; Xin Wang; Rodica Gilca; Philippe De Wals; Louise Pedneault; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

3.  Regulation of the type I protein secretion system by the MisR/MisS two-component system in Neisseria meningitidis.

Authors:  Soma Sannigrahi; Xinjian Zhang; Yih-Ling Tzeng
Journal:  Microbiology (Reading)       Date:  2009-04-16       Impact factor: 2.777

4.  Autoregulation of the MisR/MisS two-component signal transduction system in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Xiaoliu Zhou; Shaojia Bao; Shuming Zhao; Corie Noble; David S Stephens
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

Review 5.  Regulation of capsule in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Jennifer Thomas; David S Stephens
Journal:  Crit Rev Microbiol       Date:  2015-06-19       Impact factor: 7.624

6.  Translocation and surface expression of lipidated serogroup B capsular Polysaccharide in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Anup K Datta; Cristy A Strole; Michael A Lobritz; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface.

Authors:  Martine P Bos; Boris Tefsen; Jeroen Geurtsen; Jan Tommassen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

8.  Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease.

Authors:  Désirée E Bennett; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  MisR/MisS two-component regulon in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Charlene M Kahler; Xinjian Zhang; David S Stephens
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

Review 10.  Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christoph M Tang
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.